Keyphrases
Yttrium-90 Microspheres
100%
Radioembolization
100%
Hepatocellular Carcinoma
100%
Response Rate
60%
World Health Organization
60%
Time to Progression
60%
Portal Vein Thrombosis
60%
European Association for the Study of the Liver
60%
Intra-arterial
40%
Confidence Interval
40%
Child-Pugh A
40%
Child-Pugh B
40%
Overall Survival
20%
Clinical Outcomes
20%
Treatment Options
20%
Design Futures
20%
Am(III)
20%
Poor Outcome
20%
Multivariate Analysis
20%
Longitudinal Cohort Study
20%
30-day Mortality
20%
Potential Treatments
20%
Performance Status
20%
Limited Treatment Options
20%
Response Time
20%
Portal Hypertension
20%
Single Center
20%
Prospective Longitudinal Cohort
20%
Albumin
20%
Nausea-vomiting
20%
Alpha-fetoprotein
20%
By Stages
20%
Survival Time
20%
Bilirubin
20%
Overall Time
20%
Bilirubin Neurotoxicity
20%
Common Terminology Criteria
20%
Tumor Distribution
20%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Radioembolization
100%
Yttrium 90
100%
Microsphere
100%
Diseases
80%
Portal Vein Thrombosis
60%
Bilirubin
40%
Neoplasm
20%
Albumin
20%
Overall Survival
20%
Mortality Rate
20%
Cohort Analysis
20%
Multivariate Analysis
20%
Nausea and Vomiting
20%
Portal Hypertension
20%
Survival Time
20%
Fetoprotein
20%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Yttrium 90
100%
Microsphere
100%
Diseases
80%
Portal Vein Thrombosis
60%
Bilirubin
40%
Cohort Study
20%
Overall Survival
20%
Mortality Rate
20%
Nausea and Vomiting
20%
Survival Time
20%
Fetoprotein
20%
Neoplasm
20%
Portal Hypertension
20%
Albumin
20%
Biochemistry, Genetics and Molecular Biology
Microsphere
100%
Phlebothrombosis
60%
Bilirubin
40%
Cohort Study
20%
Multivariate Analysis
20%
Mortality Rate
20%
Overall Survival
20%
Survival Time
20%
Albumin
20%